Holger Amthauer

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Andreas Engert, Heinz Haverkamp, Carsten Kobe et al. · The Lancet · 2012 · 632 citations

Medicine, Oncology, Radiation Oncology +15

Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

Thomas Völker, Timm Denecke, Ingo G. Steffen et al. · Journal of Clinical Oncology · 2007 · 397 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

Jens Ricke, Heinz‐Josef Klümpen, Holger Amthauer et al. · Journal of Hepatology · 2019 · 396 citations · Full text

Medicine, Oncology, Cancer Pharmacology +13

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients

Michail Plotkin, Holger Amthauer, Stefanie Klaffke et al. · Journal of Neural Transmission · 2004 · 213 citations

Medicine, Neurology, Neuroscience +13

Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?

Timm Denecke, Beate Rau, Karl‐Titus Hoffmann et al. · European Radiology · 2005 · 206 citations

Medicine, Oncology, Radiology +17